House and Home House and Home

Paul Matteis Maintained (ALNY) at Buy with Increased Target to $152 on, Nov 10th, 2015


Published on 2024-10-25 10:34:02 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Leerink Swann, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $151 to $152 on, Nov 10th, 2015.

Paul has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Anupam Rama of "JP Morgan" Maintained at Hold with Decreased Target to $115 on, Friday, August 7th, 2015


This is the rating of the analyst that currently disagrees with Paul

  • Rahul Jasuja of "FBR Capital" Initiated at Buy and Held Target at $180 on, Tuesday, August 11th, 2015